| 0591-2511 | These highlights do not include all the information needed to use BOSENTAN TABLETS safely and effectively. See full prescribing information for BOSENTAN TABLETS. BOSENTAN tablets, for oral use Initial U.S. Approval: 2001 | Actavis Pharma, Inc. |
| 0591-2511-60 | These highlights do not include all the information needed to use BOSENTAN TABLETS safely and effectively. See full prescribing information for BOSENTAN TABLETS. BOSENTAN tablets, for oral use Initial U.S. Approval: 2001 | Actavis Pharma, Inc. |
| 0591-2512 | These highlights do not include all the information needed to use BOSENTAN TABLETS safely and effectively. See full prescribing information for BOSENTAN TABLETS. BOSENTAN tablets, for oral use Initial U.S. Approval: 2001 | Actavis Pharma, Inc. |
| 0591-2512-60 | These highlights do not include all the information needed to use BOSENTAN TABLETS safely and effectively. See full prescribing information for BOSENTAN TABLETS. BOSENTAN tablets, for oral use Initial U.S. Approval: 2001 | Actavis Pharma, Inc. |
| 47335-038 | These highlights do not include all the information needed to use BOSENTAN TABLETS safely and effectively. See full prescribing information for BOSENTAN TABLETS. BOSENTAN tablets, for oral use Initial U.S. Approval: 2001 | Sun Pharmaceutical Industries, Inc. | Sun Pharmaceutical Industries Limited |
| 47335-038-60 | These highlights do not include all the information needed to use BOSENTAN TABLETS safely and effectively. See full prescribing information for BOSENTAN TABLETS. BOSENTAN tablets, for oral use Initial U.S. Approval: 2001 | Sun Pharmaceutical Industries, Inc. | Sun Pharmaceutical Industries Limited |
| 47335-038-64 | These highlights do not include all the information needed to use BOSENTAN TABLETS safely and effectively. See full prescribing information for BOSENTAN TABLETS. BOSENTAN tablets, for oral use Initial U.S. Approval: 2001 | Sun Pharmaceutical Industries, Inc. | Sun Pharmaceutical Industries Limited |
| 47335-038-86 | These highlights do not include all the information needed to use BOSENTAN TABLETS safely and effectively. See full prescribing information for BOSENTAN TABLETS. BOSENTAN tablets, for oral use Initial U.S. Approval: 2001 | Sun Pharmaceutical Industries, Inc. | Sun Pharmaceutical Industries Limited |
| 47335-039 | These highlights do not include all the information needed to use BOSENTAN TABLETS safely and effectively. See full prescribing information for BOSENTAN TABLETS. BOSENTAN tablets, for oral use Initial U.S. Approval: 2001 | Sun Pharmaceutical Industries, Inc. | Sun Pharmaceutical Industries Limited |
| 47335-039-60 | These highlights do not include all the information needed to use BOSENTAN TABLETS safely and effectively. See full prescribing information for BOSENTAN TABLETS. BOSENTAN tablets, for oral use Initial U.S. Approval: 2001 | Sun Pharmaceutical Industries, Inc. | Sun Pharmaceutical Industries Limited |
| 47335-039-64 | These highlights do not include all the information needed to use BOSENTAN TABLETS safely and effectively. See full prescribing information for BOSENTAN TABLETS. BOSENTAN tablets, for oral use Initial U.S. Approval: 2001 | Sun Pharmaceutical Industries, Inc. | Sun Pharmaceutical Industries Limited |
| 47335-039-86 | These highlights do not include all the information needed to use BOSENTAN TABLETS safely and effectively. See full prescribing information for BOSENTAN TABLETS. BOSENTAN tablets, for oral use Initial U.S. Approval: 2001 | Sun Pharmaceutical Industries, Inc. | Sun Pharmaceutical Industries Limited |
| 66215-101 | These highlights do not include all the information needed to use TRACLEER safely and effectively. See full prescribing information for TRACLEER. TRACLEER ® (bosentan) tablets, for oral use TRACLEER ® (bosentan) tablets for oral suspension Initial U.S. Approval: 2001 | Actelion Pharmaceuticals US, Inc. | Patheon Inc. | Haupt Pharma Wuelfing GmbH | HAS Healthcare Advanced Synthesis SA | Jetpharma SA | Allpack Group AG | DIVI'S LABORATORIES LIMITED |
| 66215-101 | These highlights do not include all the information needed to use TRACLEER safely and effectively. See full prescribing information for TRACLEER. TRACLEER ® (bosentan) tablets, for oral use TRACLEER ® (bosentan) tablets for oral suspension Initial U.S. Approval: 2001 | Actelion Pharmaceuticals US, Inc. | Patheon, Inc. | Haupt Pharma Wuelfing GmbH | HAS Healthcare Advanced Synthesis SA | Jetpharma SA | Allpack Group AG | DIVI'S LABORATORIES LIMITED |
| 66215-101-03 | These highlights do not include all the information needed to use TRACLEER safely and effectively. See full prescribing information for TRACLEER. TRACLEER ® (bosentan) tablets, for oral use TRACLEER ® (bosentan) tablets for oral suspension Initial U.S. Approval: 2001 | Actelion Pharmaceuticals US, Inc. | Patheon Inc. | Haupt Pharma Wuelfing GmbH | HAS Healthcare Advanced Synthesis SA | Jetpharma SA | Allpack Group AG | DIVI'S LABORATORIES LIMITED |
| 66215-101-03 | These highlights do not include all the information needed to use TRACLEER safely and effectively. See full prescribing information for TRACLEER. TRACLEER ® (bosentan) tablets, for oral use TRACLEER ® (bosentan) tablets for oral suspension Initial U.S. Approval: 2001 | Actelion Pharmaceuticals US, Inc. | Patheon, Inc. | Haupt Pharma Wuelfing GmbH | HAS Healthcare Advanced Synthesis SA | Jetpharma SA | Allpack Group AG | DIVI'S LABORATORIES LIMITED |
| 66215-101-06 | These highlights do not include all the information needed to use TRACLEER safely and effectively. See full prescribing information for TRACLEER. TRACLEER ® (bosentan) tablets, for oral use TRACLEER ® (bosentan) tablets for oral suspension Initial U.S. Approval: 2001 | Actelion Pharmaceuticals US, Inc. | Patheon Inc. | Haupt Pharma Wuelfing GmbH | HAS Healthcare Advanced Synthesis SA | Jetpharma SA | Allpack Group AG | DIVI'S LABORATORIES LIMITED |
| 66215-101-06 | These highlights do not include all the information needed to use TRACLEER safely and effectively. See full prescribing information for TRACLEER. TRACLEER ® (bosentan) tablets, for oral use TRACLEER ® (bosentan) tablets for oral suspension Initial U.S. Approval: 2001 | Actelion Pharmaceuticals US, Inc. | Patheon, Inc. | Haupt Pharma Wuelfing GmbH | HAS Healthcare Advanced Synthesis SA | Jetpharma SA | Allpack Group AG | DIVI'S LABORATORIES LIMITED |
| 66215-102 | These highlights do not include all the information needed to use TRACLEER safely and effectively. See full prescribing information for TRACLEER. TRACLEER ® (bosentan) tablets, for oral use TRACLEER ® (bosentan) tablets for oral suspension Initial U.S. Approval: 2001 | Actelion Pharmaceuticals US, Inc. | Patheon Inc. | Haupt Pharma Wuelfing GmbH | HAS Healthcare Advanced Synthesis SA | Jetpharma SA | Allpack Group AG | DIVI'S LABORATORIES LIMITED |
| 66215-102 | These highlights do not include all the information needed to use TRACLEER safely and effectively. See full prescribing information for TRACLEER. TRACLEER ® (bosentan) tablets, for oral use TRACLEER ® (bosentan) tablets for oral suspension Initial U.S. Approval: 2001 | Actelion Pharmaceuticals US, Inc. | Patheon, Inc. | Haupt Pharma Wuelfing GmbH | HAS Healthcare Advanced Synthesis SA | Jetpharma SA | Allpack Group AG | DIVI'S LABORATORIES LIMITED |
| 66215-102-03 | These highlights do not include all the information needed to use TRACLEER safely and effectively. See full prescribing information for TRACLEER. TRACLEER ® (bosentan) tablets, for oral use TRACLEER ® (bosentan) tablets for oral suspension Initial U.S. Approval: 2001 | Actelion Pharmaceuticals US, Inc. | Patheon Inc. | Haupt Pharma Wuelfing GmbH | HAS Healthcare Advanced Synthesis SA | Jetpharma SA | Allpack Group AG | DIVI'S LABORATORIES LIMITED |
| 66215-102-03 | These highlights do not include all the information needed to use TRACLEER safely and effectively. See full prescribing information for TRACLEER. TRACLEER ® (bosentan) tablets, for oral use TRACLEER ® (bosentan) tablets for oral suspension Initial U.S. Approval: 2001 | Actelion Pharmaceuticals US, Inc. | Patheon, Inc. | Haupt Pharma Wuelfing GmbH | HAS Healthcare Advanced Synthesis SA | Jetpharma SA | Allpack Group AG | DIVI'S LABORATORIES LIMITED |
| 66215-102-06 | These highlights do not include all the information needed to use TRACLEER safely and effectively. See full prescribing information for TRACLEER. TRACLEER ® (bosentan) tablets, for oral use TRACLEER ® (bosentan) tablets for oral suspension Initial U.S. Approval: 2001 | Actelion Pharmaceuticals US, Inc. | Patheon Inc. | Haupt Pharma Wuelfing GmbH | HAS Healthcare Advanced Synthesis SA | Jetpharma SA | Allpack Group AG | DIVI'S LABORATORIES LIMITED |
| 66215-102-06 | These highlights do not include all the information needed to use TRACLEER safely and effectively. See full prescribing information for TRACLEER. TRACLEER ® (bosentan) tablets, for oral use TRACLEER ® (bosentan) tablets for oral suspension Initial U.S. Approval: 2001 | Actelion Pharmaceuticals US, Inc. | Patheon, Inc. | Haupt Pharma Wuelfing GmbH | HAS Healthcare Advanced Synthesis SA | Jetpharma SA | Allpack Group AG | DIVI'S LABORATORIES LIMITED |
| 66215-103 | These highlights do not include all the information needed to use TRACLEER safely and effectively. See full prescribing information for TRACLEER. TRACLEER ® (bosentan) tablets, for oral use TRACLEER ® (bosentan) tablets for oral suspension Initial U.S. Approval: 2001 | Actelion Pharmaceuticals US, Inc. | Patheon Inc. | Haupt Pharma Wuelfing GmbH | HAS Healthcare Advanced Synthesis SA | Jetpharma SA | Allpack Group AG | DIVI'S LABORATORIES LIMITED |
| 66215-103 | These highlights do not include all the information needed to use TRACLEER safely and effectively. See full prescribing information for TRACLEER. TRACLEER ® (bosentan) tablets, for oral use TRACLEER ® (bosentan) tablets for oral suspension Initial U.S. Approval: 2001 | Actelion Pharmaceuticals US, Inc. | Patheon, Inc. | Haupt Pharma Wuelfing GmbH | HAS Healthcare Advanced Synthesis SA | Jetpharma SA | Allpack Group AG | DIVI'S LABORATORIES LIMITED |
| 66215-103-14 | These highlights do not include all the information needed to use TRACLEER safely and effectively. See full prescribing information for TRACLEER. TRACLEER ® (bosentan) tablets, for oral use TRACLEER ® (bosentan) tablets for oral suspension Initial U.S. Approval: 2001 | Actelion Pharmaceuticals US, Inc. | Patheon, Inc. | Haupt Pharma Wuelfing GmbH | HAS Healthcare Advanced Synthesis SA | Jetpharma SA | Allpack Group AG | DIVI'S LABORATORIES LIMITED |
| 66215-103-14 | These highlights do not include all the information needed to use TRACLEER safely and effectively. See full prescribing information for TRACLEER. TRACLEER ® (bosentan) tablets, for oral use TRACLEER ® (bosentan) tablets for oral suspension Initial U.S. Approval: 2001 | Actelion Pharmaceuticals US, Inc. | Patheon Inc. | Haupt Pharma Wuelfing GmbH | HAS Healthcare Advanced Synthesis SA | Jetpharma SA | Allpack Group AG | DIVI'S LABORATORIES LIMITED |
| 66215-103-56 | These highlights do not include all the information needed to use TRACLEER safely and effectively. See full prescribing information for TRACLEER. TRACLEER ® (bosentan) tablets, for oral use TRACLEER ® (bosentan) tablets for oral suspension Initial U.S. Approval: 2001 | Actelion Pharmaceuticals US, Inc. | Patheon, Inc. | Haupt Pharma Wuelfing GmbH | HAS Healthcare Advanced Synthesis SA | Jetpharma SA | Allpack Group AG | DIVI'S LABORATORIES LIMITED |
| 66215-103-56 | These highlights do not include all the information needed to use TRACLEER safely and effectively. See full prescribing information for TRACLEER. TRACLEER ® (bosentan) tablets, for oral use TRACLEER ® (bosentan) tablets for oral suspension Initial U.S. Approval: 2001 | Actelion Pharmaceuticals US, Inc. | Patheon Inc. | Haupt Pharma Wuelfing GmbH | HAS Healthcare Advanced Synthesis SA | Jetpharma SA | Allpack Group AG | DIVI'S LABORATORIES LIMITED |
| 66215-232 | These highlights do not include all the information needed to use TRACLEER safely and effectively. See full prescribing information for TRACLEER. TRACLEER ® (bosentan) tablets, for oral use TRACLEER ® (bosentan) tablets for oral suspension Initial U.S. Approval: 2001 | Actelion Pharmaceuticals US, Inc. | Patheon Inc. | Haupt Pharma Wuelfing GmbH | HAS Healthcare Advanced Synthesis SA | Jetpharma SA | Allpack Group AG | DIVI'S LABORATORIES LIMITED |
| 66215-232 | These highlights do not include all the information needed to use TRACLEER safely and effectively. See full prescribing information for TRACLEER. TRACLEER ® (bosentan) tablets, for oral use TRACLEER ® (bosentan) tablets for oral suspension Initial U.S. Approval: 2001 | Actelion Pharmaceuticals US, Inc. | Patheon, Inc. | Haupt Pharma Wuelfing GmbH | HAS Healthcare Advanced Synthesis SA | Jetpharma SA | Allpack Group AG | DIVI'S LABORATORIES LIMITED |
| 66215-232-14 | These highlights do not include all the information needed to use TRACLEER safely and effectively. See full prescribing information for TRACLEER. TRACLEER ® (bosentan) tablets, for oral use TRACLEER ® (bosentan) tablets for oral suspension Initial U.S. Approval: 2001 | Actelion Pharmaceuticals US, Inc. | Patheon Inc. | Haupt Pharma Wuelfing GmbH | HAS Healthcare Advanced Synthesis SA | Jetpharma SA | Allpack Group AG | DIVI'S LABORATORIES LIMITED |
| 66215-232-14 | These highlights do not include all the information needed to use TRACLEER safely and effectively. See full prescribing information for TRACLEER. TRACLEER ® (bosentan) tablets, for oral use TRACLEER ® (bosentan) tablets for oral suspension Initial U.S. Approval: 2001 | Actelion Pharmaceuticals US, Inc. | Patheon, Inc. | Haupt Pharma Wuelfing GmbH | HAS Healthcare Advanced Synthesis SA | Jetpharma SA | Allpack Group AG | DIVI'S LABORATORIES LIMITED |
| 66215-232-56 | These highlights do not include all the information needed to use TRACLEER safely and effectively. See full prescribing information for TRACLEER. TRACLEER ® (bosentan) tablets, for oral use TRACLEER ® (bosentan) tablets for oral suspension Initial U.S. Approval: 2001 | Actelion Pharmaceuticals US, Inc. | Patheon, Inc. | Haupt Pharma Wuelfing GmbH | HAS Healthcare Advanced Synthesis SA | Jetpharma SA | Allpack Group AG | DIVI'S LABORATORIES LIMITED |
| 66215-232-56 | These highlights do not include all the information needed to use TRACLEER safely and effectively. See full prescribing information for TRACLEER. TRACLEER ® (bosentan) tablets, for oral use TRACLEER ® (bosentan) tablets for oral suspension Initial U.S. Approval: 2001 | Actelion Pharmaceuticals US, Inc. | Patheon Inc. | Haupt Pharma Wuelfing GmbH | HAS Healthcare Advanced Synthesis SA | Jetpharma SA | Allpack Group AG | DIVI'S LABORATORIES LIMITED |
| 68180-340 | These highlights do not include all the information needed to use BOSENTAN TABLETS FOR ORAL SUSPENSION safely and effectively. See full prescribing information for BOSENTAN TABLETS FOR ORAL SUSPENSION. BOSENTAN tablets, for oral suspension Initial U.S. Approval: 2001 | Lupin Pharmaceuticals, Inc. |
| 68180-340-13 | These highlights do not include all the information needed to use BOSENTAN TABLETS FOR ORAL SUSPENSION safely and effectively. See full prescribing information for BOSENTAN TABLETS FOR ORAL SUSPENSION. BOSENTAN tablets, for oral suspension Initial U.S. Approval: 2001 | Lupin Pharmaceuticals, Inc. |
| 68382-446 | These highlights do not include all the information needed to use BOSENTAN TABLETS safely and effectively. See full prescribing information for BOSENTAN TABLETS. BOSENTAN tablets, for oral use Initial U.S. Approval: 2001 | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited |
| 68382-446-01 | These highlights do not include all the information needed to use BOSENTAN TABLETS safely and effectively. See full prescribing information for BOSENTAN TABLETS. BOSENTAN tablets, for oral use Initial U.S. Approval: 2001 | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited |
| 68382-446-05 | These highlights do not include all the information needed to use BOSENTAN TABLETS safely and effectively. See full prescribing information for BOSENTAN TABLETS. BOSENTAN tablets, for oral use Initial U.S. Approval: 2001 | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited |
| 68382-446-14 | These highlights do not include all the information needed to use BOSENTAN TABLETS safely and effectively. See full prescribing information for BOSENTAN TABLETS. BOSENTAN tablets, for oral use Initial U.S. Approval: 2001 | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited |
| 68382-446-28 | These highlights do not include all the information needed to use BOSENTAN TABLETS safely and effectively. See full prescribing information for BOSENTAN TABLETS. BOSENTAN tablets, for oral use Initial U.S. Approval: 2001 | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited |
| 68382-446-30 | These highlights do not include all the information needed to use BOSENTAN TABLETS safely and effectively. See full prescribing information for BOSENTAN TABLETS. BOSENTAN tablets, for oral use Initial U.S. Approval: 2001 | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited |
| 68382-446-77 | These highlights do not include all the information needed to use BOSENTAN TABLETS safely and effectively. See full prescribing information for BOSENTAN TABLETS. BOSENTAN tablets, for oral use Initial U.S. Approval: 2001 | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited |
| 68382-447 | These highlights do not include all the information needed to use BOSENTAN TABLETS safely and effectively. See full prescribing information for BOSENTAN TABLETS. BOSENTAN tablets, for oral use Initial U.S. Approval: 2001 | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited |
| 68382-447-01 | These highlights do not include all the information needed to use BOSENTAN TABLETS safely and effectively. See full prescribing information for BOSENTAN TABLETS. BOSENTAN tablets, for oral use Initial U.S. Approval: 2001 | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited |
| 68382-447-05 | These highlights do not include all the information needed to use BOSENTAN TABLETS safely and effectively. See full prescribing information for BOSENTAN TABLETS. BOSENTAN tablets, for oral use Initial U.S. Approval: 2001 | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited |
| 68382-447-14 | These highlights do not include all the information needed to use BOSENTAN TABLETS safely and effectively. See full prescribing information for BOSENTAN TABLETS. BOSENTAN tablets, for oral use Initial U.S. Approval: 2001 | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited |
| 68382-447-28 | These highlights do not include all the information needed to use BOSENTAN TABLETS safely and effectively. See full prescribing information for BOSENTAN TABLETS. BOSENTAN tablets, for oral use Initial U.S. Approval: 2001 | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited |
| 68382-447-30 | These highlights do not include all the information needed to use BOSENTAN TABLETS safely and effectively. See full prescribing information for BOSENTAN TABLETS. BOSENTAN tablets, for oral use Initial U.S. Approval: 2001 | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited |
| 68382-447-77 | These highlights do not include all the information needed to use BOSENTAN TABLETS safely and effectively. See full prescribing information for BOSENTAN TABLETS. BOSENTAN tablets, for oral use Initial U.S. Approval: 2001 | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited |
| 70710-1508 | These highlights do not include all the information needed to use BOSENTAN TABLETS FOR ORAL SUSPENSION safely and effectively. See full prescribing information for BOSENTAN TABLETS FOR ORAL SUSPENSION. BOSENTAN tablets for oral suspension Initial U.S. Approval: 2001 | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited |
| 70710-1508-7 | These highlights do not include all the information needed to use BOSENTAN TABLETS FOR ORAL SUSPENSION safely and effectively. See full prescribing information for BOSENTAN TABLETS FOR ORAL SUSPENSION. BOSENTAN tablets for oral suspension Initial U.S. Approval: 2001 | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited |
| 70710-1508-8 | These highlights do not include all the information needed to use BOSENTAN TABLETS FOR ORAL SUSPENSION safely and effectively. See full prescribing information for BOSENTAN TABLETS FOR ORAL SUSPENSION. BOSENTAN tablets for oral suspension Initial U.S. Approval: 2001 | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited |
| 70771-1017 | BOSENTAN TABLETS | Zydus Lifesciences Limited |
| 70771-1017-1 | BOSENTAN TABLETS | Zydus Lifesciences Limited |
| 70771-1017-2 | BOSENTAN TABLETS | Zydus Lifesciences Limited |
| 70771-1017-4 | BOSENTAN TABLETS | Zydus Lifesciences Limited |
| 70771-1017-5 | BOSENTAN TABLETS | Zydus Lifesciences Limited |
| 70771-1017-6 | BOSENTAN TABLETS | Zydus Lifesciences Limited |
| 70771-1017-8 | BOSENTAN TABLETS | Zydus Lifesciences Limited |
| 70771-1018 | BOSENTAN TABLETS | Zydus Lifesciences Limited |
| 70771-1018-1 | BOSENTAN TABLETS | Zydus Lifesciences Limited |
| 70771-1018-2 | BOSENTAN TABLETS | Zydus Lifesciences Limited |
| 70771-1018-4 | BOSENTAN TABLETS | Zydus Lifesciences Limited |
| 70771-1018-5 | BOSENTAN TABLETS | Zydus Lifesciences Limited |
| 70771-1018-6 | BOSENTAN TABLETS | Zydus Lifesciences Limited |
| 70771-1018-8 | BOSENTAN TABLETS | Zydus Lifesciences Limited |
| 70771-1908 | Bosentan Tablets for Oral Suspension | Zydus Lifesciences Limited |
| 70771-1908-7 | Bosentan Tablets for Oral Suspension | Zydus Lifesciences Limited |
| 70771-1908-8 | Bosentan Tablets for Oral Suspension | Zydus Lifesciences Limited |